Dr. Thomas M Osborn, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 200 2nd Ave Sw, Miami, OK 74354 Phone: 918-540-7520 Fax: 918-540-7533 |
News Archive
A Kaiser Health News analysis shows that a buyer's home county may make a big difference in the insurance options they can choose from on the new online insurance marketplaces, while Politico reports that areas where co-op plans are offered are seeing lower prices.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its Board of Directors has authorized the repurchase of up to $2 million of its outstanding common stock. This decision reflects the Company's continued commitment to increasing value for its stockholders and its confidence that it will achieve its goals.
Osteoporosis is a serious health condition that affects over 44 million Americans. The human and economic costs for this condition may account for some $17 billion in direct expenditures in hospitals and nursing homes and that annual expense is expected to triple by 2040.
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).
In what is viewed as an ongoing power struggle between two branches of the federal government, the House lawyers termed the investigation related to Medicare insider-trading allegations to be a "fishing expedition."
› Verified 8 days ago